Castle Biosciences is a U.S.–based molecular diagnostics company (Nasdaq: CSTL) that develops and commercializes proprietary laboratory-developed tests aimed at providing personalized, clinically actionable information for the management of dermatologic cancers and other diseases.
Focus Areas
Notable Investments
